Work

Novel [18F]FPG-interleukin-2 conjugate for monitoring immune checkpoint therapy with positron emission tomography

Year: 2024

Type: article

Abstract: F]FPG-IL-2 based PET imaging has the potential to monitor immune checkpoint therapy.

Source: Biomedicine & Pharmacotherapy

DOI: 10.1016/j.biopha.2024.117617

Authors: Pragalath Sadasivam, Siddesh V. Hartimath, Shivashankar Khanapur, Boominathan Ramasamy, Peter Cheng, Chin Zan Feng, David Green, Julian L. Goggi, Edward G. Robins, Ran Yan

Institutions: Agency for Science, Technology and Research, National University of Singapore, King's College London, A*STAR Research Entities, South Australian Health and Medical Research Institute, The University of Adelaide

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,420

Funders: Cancer Research UK, National Institute for Health and Care Research, King's College London, King's Health Partners, Medical Research Council, Engineering and Physical Sciences Research Council, Centre For Medical Engineering, King’s College London

Awards: G1054121244, G1211483440, G1247657515, G255328453, G5296857752, Next generation molecular imaging and therapy with radionuclides, G8303168876, G8775246936, G938335843, G961285871

OpenAlex ID: W4403952268

FWCI: 0.7

Cites: 14

Cited by: 3

Related to: 10